Unrecognized Prevalence of Macrocytosis among the Patients with First Episode of Psychosis and Depression

Ramdas Sarjerao Ransing1, Suvarna Patil2, Krishna Pevekar1

  • 1Department of Psychiatry, B K L Walawalkar Rural Medical College, Ratnagiri, India.

Abstract

Insights

This study found higher rates of macrocytosis in first-episode depression and psychosis patients compared to controls. Macrocytosis may be important for understanding and treating these mental health conditions.

Area of Science:

  • Hematology
  • Psychiatry
  • Clinical Medicine

Background:

  • Macrocytosis has been linked to mood disorders and psychosis.
  • Prevalence of macrocytosis in first-episode depression and psychosis is not well-established.

Purpose of the Study:

  • To determine the prevalence of macrocytosis in patients experiencing their first episode of depression or psychosis.

Main Methods:

  • A cross-sectional study included 100 patients with first-episode depression, 100 with first-episode psychosis, and 100 healthy controls.
  • Automated coulter counter analysis of blood samples assessed hematological variables, including macrocytosis and anemia.
  • Chi-square and ANOVA tests compared variables across the three groups.

Main Results:

  • Macrocytosis prevalence was 8% in depression and 11% in psychosis, significantly higher than the 3% in healthy controls.
  • Hemoglobin concentration, mean corpuscular volume, and mean platelet volume differed significantly between patient groups and controls (P < 0.001).

Conclusions:

  • First-episode depression and psychosis patients exhibit a higher prevalence of macrocytosis than healthy individuals.
  • Macrocytosis may hold etiological and prognostic importance in these patient populations.
  • Further prospective research is recommended to clarify the clinical significance of macrocytosis in depression and psychosis.

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
41.3K
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
481
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
547